Clinical Trial: Phase 3 Evaluation of Efficacy and Safety of AR882 in Gout Patients (AR882-301)
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition:
Gout
Arthritis, Gouty
Hyperuricemia
Gout Chronic
Study Type: INTERVENTIONAL
Official Title: A Phase 3 Randomized, Double-blind, Multi-center, Placebo-controlled Study to Evaluate the Efficacy and Safety of AR882 in Participants With Gout
Brief Summary:
This study will assess the serum uric acid lowering effect and safety of AR882 in gout patients at two doses compared to placebo over 12 months
Read more